Imugene Limited (ASX:IMU)
Australia · Delayed Price · Currency is AUD 0.1900
-0.0400 (-17.39%)
At close: Mar 11, 2026
Imugene Market Cap
Imugene has a market cap or net worth of 73.95 million as of March 11, 2026. Its market cap has decreased by -73.92% in one year.
Market Cap
73.95M
Enterprise Value
64.79M
Revenue
3.94M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.19
Market Cap Chart
Since September 17, 2002, Imugene's market cap has increased from 7.38M to 73.95M, an increase of 902.18%. That is a compound annual growth rate of 10.31%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 9, 2026 | 73.95M | -36.11% |
| Dec 31, 2025 | 115.75M | -57.94% |
| Dec 31, 2024 | 275.18M | -65.11% |
| Dec 29, 2023 | 788.60M | -15.31% |
| Dec 30, 2022 | 931.15M | -59.62% |
| Dec 31, 2021 | 2.31B | 386.45% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Arovella Therapeutics | 92.95M |
| LTR Pharma | 81.80M |
| Cynata Therapeutics | 80.73M |
| Alterity Therapeutics | 76.13M |
| Radiopharm Theranostics | 74.43M |
| Prescient Therapeutics | 63.09M |
| Neurizon Therapeutics | 57.29M |
| Amplia Therapeutics | 56.44M |